Skip to main content
. 2018 Aug 6;10(7):1131–1143. doi: 10.1080/19420862.2018.1494478

Table 1.

Estimated pharmacokinetic parameters for the mPBPK model of DSTA4637A.

Parameter (unit) Definition Estimates (CV %) 95% confidence interval
σh Vascular reflection coefficient of heart 0.934 (0.683) 0.922 – 0.947
σl Vascular reflection coefficient of liver 0.957 (0.399) 0.950 – 0.965
σk Vascular reflection coefficient of kidney 0.964 (0.404) 0.956 – 0.972
σo Vascular reflection coefficient of lumped tissues 0.910 (0.804) 0.896 – 0.924
kdc (1/day) Deconjugation rate constant 0.141 (5.19) 0.126 – 0.155
CLp (ml/day/kg) TAC (DAR 0 – 2) plasma proteolytic clearance 5.26 (fixed)1  
Vp,uc-dmDNA31 (ml/kg) uc-dmDNA31 plasma volume of distribution 1.91 × 103 (17.1) 1.27 × 103 – 2.56 × 103
Vl,uc-dmDNA31 (ml/kg) uc-dmDNA31 liver volume of distribution 12.8 (92.0) 0 – 35.9
Vk,uc-dmDNA31 (ml/kg) uc-dmDNA31 kidney volume of distribution 13.5 (43.8) 1.86 – 25.1
CLp,uc-dmDNA31 (ml/day/kg) uc-dmDNA31 plasma clearance 1.28 × 104 (19.6) 7.86 × 103 – 1.77 × 104
CLl,uc-dmDNA31 (ml/day/kg) uc-dmDNA31 liver clearance 38.9 (15.8) 26.8 – 51.0
CLk,uc-dmDNA31 (ml/day/kg) uc-dmDNA31 kidney clearance 18.1 (15.6) 12.6 – 23.7

1Estimated CLp value did not change significantly using different analysis methods, including non-compartmental analysis, two-compartment model, and mPBPK model, and hence it was fixed to the average estimated value.